Bay Area's Rani Therapeutics Lands $53M as Company Moves to Clinical Trials Post author:Sam Post published:February 7, 2018 Post category:BioPharma Rani said the latest funding round brings its coffers a total of $142M. Source: BioSpace You Might Also Like Why This Pharma May be the Best CAR-T Bet, Not Gilead October 19, 2017 Johnson & Johnson Innovation, Releases Impact Report October 11, 2017 Abivax First-Half 2017 Financial Results And Update September 21, 2017
